Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

13 terminated/withdrawn out of 760 trials

Success Rate

90.6%

+4.1% vs industry average

Late-Stage Pipeline

11%

87 trials in Phase 3/4

Results Transparency

4%

5 of 126 completed trials have results

Key Signals

206 recruiting5 with results9 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
244(43.6%)
Phase 2
164(29.3%)
Phase 1
45(8.1%)
Phase 4
45(8.1%)
Phase 3
42(7.5%)
Early Phase 1
19(3.4%)
559Total
N/A(244)
Phase 2(164)
Phase 1(45)
Phase 4(45)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (760)

Showing 20 of 760 trials
NCT07492498Not ApplicableRecruiting

Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China

Role: collaborator

NCT04098471Not ApplicableRecruiting

Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer

Role: lead

NCT07731828Phase 2Recruiting

Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial

Role: lead

NCT06674187Not ApplicableRecruiting

Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery

Role: lead

NCT07492524Not ApplicableRecruiting

Novel Model of Integrated Care of Older Patients With Atrial Fibrillation and Heart Failure in Rural China (MIRACLE-AFHF)

Role: collaborator

NCT07731841Not ApplicableCompleted

Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease

Role: lead

NCT06577194Phase 2Active Not Recruiting

Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01)

Role: lead

NCT07722130Not ApplicableRecruiting

Epidural Spinal Cord Stimulation for Respiratory Recovery in Cervical SCI

Role: collaborator

NCT07718490Phase 2Recruiting

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Role: lead

NCT07719556Phase 2Recruiting

Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)

Role: lead

NCT07717242Phase 2Recruiting

Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

Role: collaborator

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Role: collaborator

NCT06543992Phase 2Recruiting

Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis

Role: lead

NCT07180303Not ApplicableCompleted

Colorectal Cancer Screening in Chinese Rural Communities

Role: lead

NCT07606820Not ApplicableCompleted

Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea

Role: lead

NCT07716111Phase 2Not Yet Recruiting

Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma

Role: lead

NCT07712445Recruiting

Study on the Thrombolytic Effect of Platelet Membrane Coated Tenecteplase on Human Arterial Thrombus

Role: lead

NCT07464756Phase 2Recruiting

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Role: lead

NCT07612670Not Yet Recruiting

A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy

Role: lead

NCT07698366Not ApplicableNot Yet Recruiting

Ultrasound Screening for Early Detection of Breast Cancer in Elderly Women: A Mixed Cluster-Individual RCT

Role: lead